The role of UNFPA in promoting women's issue through the development of innovative strategies and partnership with businesses to build upon the work that has been done to meet the MDGs, including gender equality and access to SRH.
Representative from the UNFPA Technical Division, Director of Programs, UN Fund for Population.

Impact of education and preventative healthcare on women and girls. Building collaborations to provide positive education that could impact the health of women and girls in order to prevent AIDS related cancer in girls and young women, and educational support for preventative healthcare in relation to the health of women and young girls.
Dr. Josephine Nkiru-Edna Alumanah, Ph.D. Senior Lecturer at the University of Nigeria, Nsukka and Executive Director of Action in Distress (AID) Foundation in Nigeria.

Immunization for prevention of AIDS related cervical cancer in girls and young women.
Collaboration with private and public partners to develop new technologies to prevent AIDS Related cancer in girls and women, and educational support for preventative healthcare in relation to the health of women and young girls.
Dr. (Mrs) Nwadiuto Afonne Akani, Senior Lecturer and Consultant Paediatrician, University of Port Harcourt, Nigeria.

An Insurance Fund to help women vendors access to health care in Lagos:
A Public Private Partnership pilot program with the support of the Dutch government and businesses,, Unilever, Shell and Heineken.
Representative of the Insurance Fund project based in Lagos, Nigeria.

Role of business women networks to increase access to prevention and care
Impact of two programs the GOWE - Growth Oriented Women Entrepreneurs for business women in Kenya and the FACE - Femmes Africaines Chefs d'Enterprises a fort potential de crosissance in Cameroon in partnership with the French Development Agency.
Leila Mokaddem, Principal Investment Economist, African Development Bank.

Questions and Answers

Networking Coffee Break Sponsored by Access Bank PLC.

SESSION 4
PUBLIC PRIVATE PARTNERSHIP FOR TUBERCULOSIS AND MALARIA

Opening remarks chaired by Dr Prosper Igboeli, President of the Nigerian Medical Association.

Nets for Life. Corporate Social Responsibility in the fight against Malaria in partnerships with the Nigeria Government, businesses and communities across Africa.
Dr Paul Essomba, Medical director of Cotco, Exxon Mobi,l Cameroon.

Marketing of Mosquito Nets in Africa to aid prevention and care Exploiting local content and technology across communities in Africa to ensure that nets are publicly accessible, even in remote areas.
Mr. Kim Rasmussen, Regional Director, Vestergaard-Frandsen, Nigeria.

Research and Development to fight Malaria, Partnering with the Nigerian Government, and businesses and communities across Africa.
Mr Diane Watson Director , Global Vaccine Policies and Public Health Partnerships Department,GlaxoSmithKline (GSK) Biologicals, Belgium.

Partnerships with governments, businesses and NGOs against Malaria experiences in Africa.
Dr René Cazetien, Director, Sales Operations and Market Research Access to Medicines, Sanofi-aventis.

The importance of Partnerships for TB prevention, control and care.
Mrs Nelly Enwerem-Bromson, Stop TB Partnership, World Health Organization.

Lunch sponsored by Novo Nordisk

SESSION 5
DIABETES IN AFRICA

Chaired by Dr. Debo Magbagbeoma, Secretary General, National Diabetes Association of Nigeria. Welcome remarks and about Diabetes in Nigeria and sub Saharan Africa.

Diabetes in Africa and alliances for prevention The growth of all types of diabetes in Africa, its influence upon heart diseases and impact on under resourced national health services: working to combat the disease at corporate community and national levels, in partnership with the Nigerian and regional governments on issues of social responsibility in relation to diabetes.
Drs. Kaubnik Ramauya and Mbelenge Mapoko Llondo, Director for Africa, Novo Nordisk.

Links between HIV/AIDS and diabetes. The amount of Diabetics contracting HIV and AIDS is increasing in Africa but as yet there is no concrete information about how AIDS is affecting their lives.
Drs. Kaubnik Ramauya and Mbelenge Mapoko Llondo, Director for Africa, Novo Nordisk.

Chaired by Drs. Alexandra Graham, La Gray Pharmaceutical Ltd and co-chaired by Therese Lethu, GBC.

Closing Remarks

---------------------------- END OF DAY TWO ------------------------------